Condition
Resectable Lung Non-Small Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Resectable Lung Non-Small Cell Carcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (4), China (2), France (1)). By phase: Phase 2 (4), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 4Countries
Newest Resectable Lung Non-Small Cell Carcinoma clinical trials
All recruiting trials (8)
-
Adaptive Chemotherapy for PD-L1 High Resectable NSCLC: A Chemo-PHREE Trial
This study tests cemiplimab in adults with resectable non-small cell lung cancer to see if surgery can be pursued without preceding chemotherapy for some patients.
-
Resiliency and Operative Success for Lung Cancer Surgery: Prehab with In-Person and BeFitMe Options
This trial tests two prehab programs—one in-person and one virtual—to see if pre- and post-surgery physical therapy and relaxation help adults undergoing lung cancer surgery feel steadier and have better recovery.
-
Combining adebrelimab with chemotherapy for lung cancer treatment
This study is testing if adding adebrelimab to chemotherapy helps patients with early-stage lung cancer feel better and have better treatment outcomes before surgery.
-
Treatment for lung cancer patients who had surgery but are not disease-free
This study is testing two new immunotherapy treatments for lung cancer patients who have had surgery but still have some disease to see if they can help them stay cancer-free longer.
-
Predicting how tumors respond to immune therapies using a live diagnostic platform
This study is testing a new way to predict how well immune therapies will work for patients with different types of solid tumors, including early-stage and metastatic cancers.
-
How surgical approach affects posture-breathing coordination after lobectomy
This study will see if minimally invasive lobectomy (robotic or video-assisted) versus traditional thoracotomy changes how posture and breathing coordinate in people having surgery for resectable non-small cell lung cancer.
-
Combining camrelizumab with chemotherapy for lung cancer treatment
This study is testing if combining a new drug called camrelizumab with chemotherapy can help people with certain types of lung cancer before surgery.
-
Proton beam radiation therapy for lung cancer after surgery
This study tests whether proton beam radiation therapy can help prevent lung cancer from coming back in patients who have already had surgery to remove the tumor.
Related topics
Quick answers
How many Resectable Lung Non-Small Cell Carcinoma clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (4 trials), China (2 trials), France (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.